activity
20202022
most citedTrademark filings and patent application count time series are structurally near-identical and cointegrated: Implications for studies in innovation

6 citations · 15 across the 4 of their papers we have counts for

collaborators

5 papers

econ.GN20222 cited

Singular Secular Kuznets-like Period Realized Amid Industrial Transformation in US FDA Medical Devices: A Perspective on Innovation from 1976 to 2020

Iraj Daizadeh

Introduction: Since inception, the United States (US) Food and Drug Administration (FDA) has kept a robust record of regulated medical devices (MDs). Based on these data, can we ga…

econ.GN20212 cited

Seasonal and Secular Periodicities Identified in the Dynamics of US FDA Medical Devices (1976 2020) Portends Intrinsic Industrial Transformation and Independence of Certain Crises

Iraj Daizadeh

Background: The US Food and Drug Administration (FDA) regulates medical devices (MD), which are predicated on a concoction of economic and policy forces (e.g., supply/demand, crise…

econ.GN2021

Leveraging latent persistency in United States patent and trademark applications to gain insight into the evolution of an innovation-driven economy

Iraj Daizadeh

Objective: An understanding of when one or more external factors may influence the evolution of innovation tracking indices (such as US patent and trademark applications (PTA)) is…

econ.EM20206 cited

Trademark filings and patent application count time series are structurally near-identical and cointegrated: Implications for studies in innovation

Iraj Daizadeh

Through time series analysis, this paper empirically explores, confirms and extends the trademark/patent inter-relationship as proposed in the normative intellectual-property (IP)-…

econ.EM20205 cited

United States FDA drug approvals are persistent and polycyclic: Insights into economic cycles, innovation dynamics, and national policy

Iraj Daizadeh

It is challenging to elucidate the effects of changes in external influences (such as economic or policy) on the rate of US drug approvals. Here, a novel approach, termed the Chron…